Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa.
Simona DedoniMaria SchermaChiara CamoglioCarlotta SiddiWalter FrattaPaola FaddaPublished in: Nutrients (2023)
The pathophysiology of Anorexia Nervosa (AN) has not been fully elucidated. Anaplastic lymphoma kinase (ALK) receptor is a protein-tyrosine kinase mainly known as a key oncogenic driver. Recently, a genetic deletion of ALK in mice has been found to increase energy expenditure and confers resistance to obesity in these animals, suggesting its role in the regulation of thinness. Here, we investigated the expression of ALK and the downstream intracellular pathways in female rats subjected to the activity-based anorexia (ABA) model, which reproduces important features of human AN. In the hypothalamic lysates of ABA rats, we found a reduction in ALK receptor expression, a downregulation of Akt phosphorylation, and no change in the extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) phosphorylation. After the recovery from body weight loss, ALK receptor expression returned to the control baseline values, while it was again suppressed during a second cycle of ABA induction. Overall, this evidence suggests a possible involvement of the ALK receptor in the pathophysiology of AN, that may be implicated in its stabilization, resistance, and/or its exacerbation.
Keyphrases
- tyrosine kinase
- anorexia nervosa
- advanced non small cell lung cancer
- transcription factor
- epidermal growth factor receptor
- weight loss
- signaling pathway
- binding protein
- cell proliferation
- protein kinase
- endothelial cells
- metabolic syndrome
- type diabetes
- arabidopsis thaliana
- chronic obstructive pulmonary disease
- insulin resistance
- poor prognosis
- skeletal muscle
- intensive care unit
- weight gain
- roux en y gastric bypass
- genome wide
- physical activity
- small molecule
- mass spectrometry
- copy number
- reactive oxygen species
- gastric bypass
- induced pluripotent stem cells
- long non coding rna